Strategic Plan 2008-2012
Vision
To progress as a preeminent community-based medical school that advances new models of academic excellence and community health care.
Mission
To educate culturally diverse students to become excellent physicians by focusing on generalist training that is integrated, supported, and strengthened by specialists and researchers, all of whom value patient-focused care, community service, and research, and have passion for improving health in their communities.
Goal 1: To foster a distinctive teaching and learning culture of intellectual curiosity, excitement and growth |
||
Objective A: Integrate new information & technology |
||
|
Strategy 1 |
Outcome Measure |
Timeline |
|
Establish a simulation center |
|
|
Objective B: Improve Research Opportunities for Students |
||
|
Strategy 2 |
Outcome Measure |
Timeline |
|
Create administrative infrastructure to promote student research |
|
|
Objective C: Support Students Serving Communities |
||
|
Strategy 3 |
Outcome Measure |
Timeframe |
|
Transform many of the current electives and volunteer activities into designated Service Learning |
|
|
Goal 2: To enhance faculty development to further support the educational, clinical and research mission. |
||
Objective A: Enhance Faculty Education |
||
|
Strategy 1 |
Outcome Measure |
Timeframe |
|
Develop “residents as teachers” course and offer to all trainees in residency/fellowship programs |
|
|
|
Strategy 2 |
Outcome Measure |
Timeframe |
|
Develop a teaching skills course for all faculty |
|
|
|
Strategy 3 |
Outcome Measure |
Timeframe |
|
Support opportunities for faculty development fellowships and courses |
|
|
Goal 3: To increase and diversify revenue sources to support the educational, clinical and research mission |
||
Objective A: Increase State and Federal Funding |
||
|
Strategy 1 |
Outcome Measure |
Timeframe |
|
Lobby at the federal and state levels for increased funds, and develop process to maximize the use of the university government relations specialist |
|
|
Objective B: Increase Opportunities for Private Support |
||
|
Strategy 1 |
Outcome Measure |
Timeframe |
|
Enhance community partnershipsIncrease the number of WSP physicians (Refer to Goal 5, Objective C, Strategy 2) |
|
|
|
Strategy 2 |
Outcome Measure |
Timeframe |
|
Increase alumni, other individuals, foundation and corporate giving
|
|
|
|
Strategy 3 |
Outcome Measure |
Timeframe |
|
Target an increase in scholarships |
|
|
|
Strategy 4 |
Outcome Measure |
Timeframe |
|
Educate and engage senior faculty in fundraising activities and responsibilities |
|
|
Goal 4: To accelerate research growth and achievement by targeted investment in clinical and basic science funded research |
||
Objective A: Identify and prioritize the school’s research infrastructure and short and long-term needs and opportunities |
||
|
Strategy 1 |
Outcome Measure |
Timeframe |
|
Create a visionary task force of clinical and basic science chairs, chaired by the associate dean for research, to recommend and monitor investment and achievement in research and design and implement a Planning Grant Program to facilitate preparation of major proposals |
|
|
|
Strategy 2 |
Outcome Measure |
Timeframe |
|
Create database of funded clinical and basic research to inform investment and facilitate synergistic interactions |
|
|
Objective B: Increase number and competitiveness of major external research-based multi-disciplinary proposals |
||
|
Strategy 1 |
Outcome Measure |
Timeframe |
|
Promote clustering of researchers targeting common problems and capitalize on existing strengths and infrastructure of the School of Medicine |
|
|
|
Strategy 2 |
Outcome Measure |
Timeframe |
|
Utilize external grant consultants/lobbyists to identify and target appropriate programs, provide advocacy, and assist with grant submission (e.g. FreeMind). |
|
|
|
Strategy 3 |
Outcome Measure |
Timeframe |
|
Align with State (e.g. Third Frontier) and Community (e.g. DDC) objectives and initiatives (including BRAC process). |
|
|
Objective C: Hire at least one to two established (funded) clinical investigators each year over the next five years |
||
|
Strategy 1 |
Outcome Measure |
Timeframe |
|
Create a clinical/translational research facility and develop capacity to conduct clinical trials. |
|
|
|
Strategy 2 |
Outcome Measure |
Timeframe |
|
Hire additional established clinical investigators in clinical departments. |
|
|
|
Strategy 3 |
Outcome Measure |
Timeframe |
|
Increase synergy between clinical departments and between clinical and basic science departments. |
|
|
Goal 5: To enhance strategic engagements with organizations and the communities we serve |
||
Objective A: Identify the characteristics, features and elements for strategic engagements. |
||
|
Strategy 1 |
Outcome Measure |
Timeframe |
|
List the principles and caveats related to strategic engagements undertaken by the School of Medicine |
|
|
|
Strategy 2 |
Outcome Measure |
Timeframe |
|
Write a document that lists the explicit criteria describing a strategic engagement between the School of Medicine and any potential partner |
|
|
Objective B: Evaluate existing and future engagements with respect to outcomes such as education, research and scholarship; service; revenue; and/or quality of care. |
||
|
Strategy 1 |
Outcome Measure |
Timeframe |
|
Develop a tool that evaluates a strategic engagement with respect to:
|
|
|
|
Strategy 2 |
Outcome Measure |
Timeframe |
|
Test and refine the tool by applying it to existing strategic engagements |
|
|
Objective C: Promote the value of engaging with Boonshoft School of Medicine to internal and external audiences. |
||
|
Strategy 1 |
Outcome Measure |
Timeframe |
|
Raise awareness about Boonshoft School of Medicine’s desire to develop strategic engagements with WSU, emphasizing potential benefits for all parties |
|
|
|
Strategy 2 |
Outcome Measure |
Timeframe |
|
Raise awareness about Boonshoft School of Medicine’s desire to develop strategic engagements including but not limited to VAMC, WPAFB, health care and hospital systems, and community agencies and organizations, emphasizing potential benefits for all parties.(Refer to Goal 3, Objective A, Strategy 1) |
|
|
Approved by the Boonshoft School of Medicine Executive Committee, January 10, 2008.